Thermo Fisher's Q1 Results Show Why It's a Safe Growth Stock to Own
Thermo Fisher Scientific (NYSE: TMO) is a top international healthcare company with a market cap of over $210 billion. The business is robust and always finding new ways to grow. It recently released its first-quarter results for 2022, which confirmed what many investors already know: This is an incredibly safe stock to hold in your portfolio.
Not only did revenue rise significantly due to an acquisition, but the rest of Thermo Fisher's numbers also looked solid. Here's a look at how the company performed in Q1 and what should stand out to investors.
Image source: Getty Images.
Source Fool.com
